![]() |
|
Names | |
---|---|
IUPAC name
4-(2-(7-amino-2-(furan-2-yl)-[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-ylamino)ethyl)phenol
|
|
Identifiers | |
139180-30-6 ![]() |
|
3D model (Jmol) | Interactive image |
ChEMBL |
ChEMBL113142 ![]() |
ChemSpider |
153646 ![]() |
ECHA InfoCard | 100.216.533 |
405 | |
PubChem | 176407 |
|
|
|
|
Properties | |
C16H15N7O2 | |
Molar mass | 337.34 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
![]() ![]() ![]() |
|
Infobox references | |
ZM-241,385 is a high affinity antagonist ligand selective for the adenosine A2A receptor.
In animal models, ZM-241,385 has been shown to protect against beta amyloid neurotoxicity and therefore may be useful as a treatment for Alzheimer's disease. ZM-241,385 has also been shown to enhance L-DOPA derived dopamine release and therefore may be useful in the treatment of Parkinson's disease.
ZM 241385 at the US National Library of Medicine Medical Subject Headings (MeSH)